Advertisement

HindustanTimes Fri,26 Dec 2014

Dr Reddy's launches generic Zoledronic Acid injection in US

PTI  New Delhi, April 04, 2013
First Published: 12:39 IST(4/4/2013) | Last Updated: 12:43 IST(4/4/2013)

Drug firm Dr Reddy's Laboratories on Thursday said it has launched generic Zoledronic Acid injection used for treating osteoporosis and Paget's disease of bone in the US market following approval from the US health regulator.

Advertisement

The company has launched Zoledronic Acid injection (5 mg/100 mL) on Wednesday, following approval of its abbreviated new drug application (ANDA) by the US Food & Drug Administration (USFDA), Dr Reddy's Laboratories said in a statement.

The product is generic version of Novartis AG's Reclast injection in the same strength, it added.

"The Reclast brand had total US sales of approximately USD 355 million for the most recent twelve months ending February, 2013 according to IMS Health," Dr Reddy's said.

The company's Zoledronic Acid injection is available in a single use vial for intravenous infusion, it added.

Paget's disease of bone is a chronic disorder that can result in enlarged and misshapen bones.

Shares of Dr Reddy's Laboratories were today trading at Rs. 1,888.60 apiece on the BSE in afternoon trade, up 2.93% from their previous close.


Advertisement
more from Business

Reliance Cap ropes in Japanese bank as partner

Firming up its plans to set up a bank, Anil Ambani-led Reliance Capital on Thursday roped in Japan’s Sumitomo Mitsui Trust Bank (SMTB) as a strategic partner and minority investor to collaborate on various businesses, including its proposed banking venture.
markets
Advertisement
Most Popular
Advertisement
Advertisement
Copyright © 2014 HT Media Limited. All Rights Reserved